AQR Capital Management »

Arrivent Biopharma shares owned by AQR Capital Management

Quarter-by-quarter ownership of Arrivent Biopharma (AVBP) shares owned by AQR Capital Management from 13F filings

Historical chart of AQR Capital Management investment in Arrivent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arrivent Biopharma held by AQR Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrivent Biopharma by AQR Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $236k 8.9k 26.64
2024-09-30 $204k 8.7k 23.52

More positions owned by AQR Capital Management

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Zoom Communications Cl A (ZM)
Ge Aerospace Com New (GE)
Cme (CME)
Alphabet Cap Stk Cl C (GOOG)
Merck & Co (MRK)
McKesson Corporation (MCK)
Alphabet Cap Stk Cl A (GOOGL)
Johnson & Johnson (JNJ)
Eli Lilly & Co. (LLY)

View all positions for AQR Capital Management

Top funds holding Arrivent Biopharma

Hillhouse Capital Advisors
OrbiMed Advisors
Suvretta Capital Management
BlackRock
FMR
Octagon Capital Advisors
Sofinnova Ventures
Infinitum Asset Management
Novo A/S
General Catalyst Group Management
Vanguard Group
State Street Corporation
Sc China Holding
Geode Capital Management
Cormorant Asset Management

View all funds holding Arrivent Biopharma